| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
2e-20 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.34 |
2e-20 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-15 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-13 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
7e-12 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-11 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
4e-11 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
5e-11 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-10 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-10 |